JUHE:XETRA:XETRA-JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity UCITS ETF - EUR Hedged (acc) (EUR)

ETF | Others |

Last Closing

USD 44.805

Change

-0.38 (-0.84)%

Market Cap

N/A

Volume

312.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.13 (+0.25%)

USD 548.90B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.05 (+0.30%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.05 (+0.17%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.08 (+0.29%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.15 (+0.61%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+0.96 (+0.65%)

USD 103.20B
JARI:XETRA Amundi Index Solutions - Amund..

+0.22 (+0.50%)

USD 102.92B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.16 (+0.30%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+0.60 (+0.11%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.05 (+0.20%)

USD 79.79B

ETFs Containing JUHE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.91% 84% B 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.91% 84% B 81% B-
Trailing 12 Months  
Capital Gain 23.55% 83% B 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.55% 83% B 82% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.12% 72% C 69% C-
Dividend Return 9.12% 71% C- 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.33% 50% F 60% D-
Risk Adjusted Return 73.91% 86% B+ 86% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.